Capsaicin's effect on rat nasal mucosa substance P release: experimental basis for vasomotor rhinitis treatment.
Substance P (SP) is one of several neuropeptides found in nasal mucosa. It exists primarily in sensory afferent neurons, which are best demonstrated by immunohistochemical staining. These substance P-like immunoreactive (SPLI) nerve fibers are unmyelinated C fibers, which connect to the trigeminal ganglion and the spinal trigeminal nucleus. They are found around vessels and seromucinous glands in the submucosa. When the nasal mucosa receives a noxious stimulus, SP is released and acts orthodromically as a comediator of nasal pain, while antidromically it induces vasodilatation, plasma extravasation, mucosal edema, and rhinorrhea. Its antidromic effects have been implicated in vasomotor rhinitis and can be blocked by topical intranasal capsaicin application. Wolf and others have demonstrated in human subjects that vasomotor rhinitis can be blocked up to 1 year by a series of intranasal capsaicin applications. It has not yet been demonstrated that nasal mucous SP levels following noxious nasal stimulus change after intranasal capsaicin pretreatment. Consequently a project was designed to determine whether intranasal capsaicin pretreatment would affect nasal substance P release measured in nasal secretion. Nasal secretion SP levels were measured before and after noxious nasal stimulus in controls and in capsaicin pretreated rats. The difference in measured nasal secretion SP levels were significant (p < 0.05).
Kuhn
F A
FA
Georgia Rhinology and Sinus Center, Georgia Ear Institute, Savannah 31403-3665, USA.
Gonzalez
S
S
Rodriguez
M
M
Siller
C C
CC
Zachariou
V
V
Goldstein
B D
BD
D000281:Administration, Intranasal; D000818:Animals; D002211:Capsaicin / Q000008:administration & dosage / Q000494:pharmacology*; D005122:Exudates and Transudates / Q000378:metabolism; D008297:Male; D009297:Nasal Mucosa / Q000187:drug effects* / Q000378:metabolism; D009299:Nasal Provocation Tests; D051381:Rats; D011920:Rats, Inbred WF; D012220:Rhinitis / Q000188:drug therapy*; D013373:Substance P / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*
D013373:Substance P; D002211:Capsaicin